These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 696780)

  • 1. Dramatic pyrexic and cardiovascular response to intravaginal prostaglandin E2.
    Phelan JP; Meguiar RV; Matey D; Newman C
    Am J Obstet Gynecol; 1978 Sep; 132(1):28-32. PubMed ID: 696780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of labor in patients with missed abortion and fetal death in utero with protaglandin E2 suppositories.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1977 Mar; 127(6):609-11. PubMed ID: 557289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of missed abortion and fetal death in utero.
    el-Damarawy H; el-Sahwi S; Toppozada M
    Prostaglandins; 1977 Sep; 14(3):583-90. PubMed ID: 905580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
    Scher J; Jeng DY; Moshirpur J; Kerenyi TD
    Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal prostaglandin E2 in the management of fetal intrauterine death.
    Southern EM; Gutknecht GD; Mohberg NR; Edelman DA
    Br J Obstet Gynaecol; 1978 Jun; 85(6):437-41. PubMed ID: 350261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 induction of labor for fetal demise.
    Kent DR; Goldstein AI
    Obstet Gynecol; 1976 Oct; 48(4):475-8. PubMed ID: 967387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of induction of labor by vaginal suppositories containing prostaglandin E2.
    Liggins GC
    Prostaglandins; 1979 Jul; 18(1):167-72. PubMed ID: 392623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracervical instillation of PGE2-gel in patients with missed abortion or intrauterine fetal death.
    Ekman G; Uldbjerg N; Wingerup L; Ulmsten U
    Arch Gynecol; 1983; 233(4):241-5. PubMed ID: 6660917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of postpartum uterine atony with prostaglandin E2 vaginal suppositories.
    Hertz RH; Sokol RJ; Dierker LJ
    Obstet Gynecol; 1980 Jul; 56(1):129-30. PubMed ID: 6966776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage forms.
    Roseman TJ; Gutknecht GD; Stehle RG; Southern EM
    Am J Obstet Gynecol; 1977 Sep; 129(2):225-7. PubMed ID: 19973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
    Thiery M; Amy JJ; Decoster JM
    Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
    Hochman M; Laufe LE
    J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal prostaglandin E2 for missed abortion and intrauterine fetal death.
    Rutland A; Ballard C
    Am J Obstet Gynecol; 1977 Jul; 128(5):503-6. PubMed ID: 879208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravaginal prostaglandin E2 for cervical ripening and induction of labour. A comparison of gel and tablets.
    Davey DA; Dommisse J; MacNab M
    S Afr Med J; 1980 Sep; 58(13):516-8. PubMed ID: 7423283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 vaginal suppositories for therapeutic abortion.
    Newman C; Bailey CD; Ellinas SP; Anderson GG
    Adv Plan Parent; 1975; 10(1):34-8. PubMed ID: 1164986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.